CLASSIC KAPOSI SARCOMA

Clinical trials for CLASSIC KAPOSI SARCOMA explained in plain language.

Never miss a new study

Get alerted when new CLASSIC KAPOSI SARCOMA trials appear

Sign up with your email to follow new studies for CLASSIC KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Cancer combo drug trial for rare skin cancer withdrawn before starting

Disease control Terminated

This study planned to test a combination of two drugs, pembrolizumab and lenvatinib, in people with a rare skin cancer called classic Kaposi sarcoma that had not responded to prior chemotherapy. The goal was to see if the combination could shrink tumors better than standard chemo…

Matched conditions: CLASSIC KAPOSI SARCOMA

Phase: PHASE2 • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Disease control

Last updated Jun 27, 2026 08:13 UTC

CLASSIC KAPOSI SARCOMA

Get alerted when new CLASSIC KAPOSI SARCOMA trials appear

Cancer combo drug trial for rare skin cancer withdrawn before starting